Skip to content
Screener

McKesson MCK Total Revenue

Total Revenue at other companies

Eli Lilly logo
Eli LillyLLY
$22.97B+47.7%
Cardinal Health, Inc. logo
Cardinal Health, Inc.CAH
$63.67B+5.8%
Cencora logo
CencoraCOR
$84.75B+5.1%
AbbVie logo
AbbVieABBV
$16.99B+10.2%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$796.2M+9.9%
Viatris logo
ViatrisVTRS
$3.76B+4.9%

Segments

By segment

See full
North American Pharmaceutical$86.77B
Oncology & Multispecialty$14.22B
Medical-Surgical Solutions$2.82B+4.4%
Prescription Technology Solutions$1.57B+9.2%

Other financials

Income statement

See full
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$104.54B+23.0%
Enterprise value$112.25B+20.0%
P/E22.8×-4.1×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025
Revenues$105,380$97,827
Cost of sales(101,695)(94,548)
Gross profit3,6853,279
Selling, distribution, general, and administrative expenses(2,264)(2,196)
Claims and litigation charges, net34
Restructuring, impairment, and related charges, net(136)(47)
Total operating expenses(2,366)(2,243)
Operating income1,3191,036

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's total revenue?
McKesson (MCK) reported total revenue of $105.38B in Q2 2026.
How has McKesson's total revenue changed year-over-year?
McKesson's total revenue increased by 7.7% year-over-year, from $97.83B to $105.38B.
What is the long-term trend for McKesson's total revenue?
Over 4 years (2022 to 2026), McKesson's total revenue has grown at a 11.2% compound annual growth rate (CAGR), from $263.97B to $403.43B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about McKesson's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude